Lindahl acted as legal advisor to Corline Biomedical
Through the agreement, Imperative Care is given the exclusive right to use CHS™ in all types of neurovascular products given a certain level of compensation. Corline undertakes to supply CHS™-coated products according to defined specifications, but also to assist in further development and market registration of the current product. In addition, Corline will participate in the development of additional CHS™-coated products within the indication area. These products have the potential to generate revenue for Corline of approximately SEK 150 million per year and a total of more than SEK 1 billion.
Lindahl's team consisted of Hugo Norlén and Erika Svensson.
Corline's press release (in Swedish) is available here.
Do you want to know more? Contact:
Hugo Norlén
Partner | AdvokatErika Svensson
Partner | AdvokatCarousel items
-
Knowledge
8/21/2026
Properly prepared — contract law in the new security landscape part 2
How to handle contract law in the new security landscape – amendment clauses, preventive contract tools and security clearance issues.
-
Cases and transactions
8/14/2026
Lindahl advises dLaboratory Sweden AB (publ) on agreement to acquire Techinova AB
Lindahl has advised dLaboratory Sweden AB (publ) on the agreement to acquire all shares in Swedish technology company Techinova AB.
-
News articles
7/7/2026
Lindahl included among Sweden's ten most reputable patent firms for the second consecutive year
For the second consecutive year, Lindahl has been named among Sweden's ten most reputable patent law firms by The Patent Lawyer Magazine – a testament to the firm's strong expertise and long-term commitment in intellectual property law.
-
Portraits
7/3/2026
Jesper on business-oriented legal advice in energy: "It is not enough for the advice to be correct"
Lindahl's energy team is recognised in Legal 500 for combining deep regulatory expertise with broad commercial legal experience – find out how they support clients in a rapidly evolving sector.
-
Read more news and insights?